Rho GTPases play a central role in neuronal survival; however, the antagonistic relationship between Rac and Rho in the regulation of motor neuron survival remains poorly defined. In the current study, we demonstrate that treatment with NSC23766, a selective inhibitor of the Rac-specific guanine nucleotide exchange factors, Tiam1 and Trio, is sufficient to induce the death of embryonic stem cell (ESC)-derived motor neurons. The mode of cell death is primarily apoptotic and is characterized by caspase-3 activation, de-phosphorylation of ERK5 and AKT, and nuclear translocation of the BH3only protein Bad. As opposed to the inhibition of Rac, motor neuron cell death is also induced by constitutive activation of Rho, via a mechanism that depends on Rho kinase (ROCK) activity. Investigation of Rac and Rho in the G93A mutant, human Cu, Zn-superoxide dismutase (hSOD1) mouse model of amyotrophic lateral sclerosis (ALS), revealed that active Rac1-GTP is markedly decreased in spinal cord motor neurons of transgenic mice at disease onset and end-stage, when compared to age-matched wild type (WT) littermates. Furthermore, although there is no significant change in active RhoA-GTP, total RhoB displays a striking redistribution from motor neuron nuclei in WT mouse spinal cord to motor neuron axons in end-stage G93A mutant hSOD1 mice. Collectively, these data suggest that the intricate balance between pro-survival Rac signaling and pro-apoptotic Rho/ROCK signaling is critical for motor neuron survival and therefore, disruption in the balance of their activities and/or localization may contribute to the death of motor neurons in ALS. J o u r n a l P r e -p r o o f Journal Pre-proof of a Rac-dependent pro-survival pathway (Kanekura et al., 2005). Finally, another study identified that ARHGEF16, a Rac GEF (Blanke and Jäckle, 2008), is hyper-methylated and downregulated in sporadic ALS patients (Figueroa-Romero et al., 2012). Collectively, these findings indicate that diminished Rac activity may be a common factor underlying the death of motor neurons in both familial and sporadic ALS.
Introduction
ALS is a devastating and progressive neurodegenerative disease characterized by severe muscle weakness and atrophy due to loss of motor neurons in the spinal cord, brain stem, and motor cortex. Following diagnosis, ALS patients typically survive 2-5 years and succumb to death due to respiratory failure. Approximately 90% of ALS cases are sporadic while the remaining 10% are caused by a genetic component. Mutations in SOD1 account for approximately 20% of all familial cases of ALS. Although the mechanism of motor neuron loss in ALS is presently unclear, recent findings suggest that dysregulated Rho family GTPase activity may be a contributing factor.
Rho family GTPases are monomeric G-proteins of the Ras superfamily that regulate neuronal morphology and neuronal survival (Linseman and Loucks, 2008; Stankiewicz and Linseman, 2014) . Specifically, Rac elicits neurite outgrowth and neuronal survival while Rho provokes neurite retraction and neuronal apoptosis (Luo, 2000) . For example, we have previously shown in primary cerebellar granule neurons (CGNs) that inhibition of Rac or overexpression of a dominant negative Rac1 mutant induces mitochondrial-dependent apoptosis (Linseman et al., 2001; Le et al., 2005; Loucks et al., 2006; Stankiewicz et al., 2012; Stankiewicz et al., 2015) . Conversely, RhoA activation in CGNs elicits apoptosis following glutamate-induced excitotoxity (Semenova et al., 2007) . Thus, tight regulation of Rho family GTPase activity is essential for neuronal survival.
Additional studies suggest that diminished Rac activity and/or enhanced Rho activity may underlie neurodegenerative diseases such as ALS. Indeed, dominant negative Rac expression induces apoptosis of cultured motor neurons and inactivation of Rac is required for G93A mutant SOD1-induced apoptosis of SH-SY5Y neuroblastoma cells (Jacquier et al., 2006; Pesaresi et al., 2011) . Further, loss-of-function mutations in a Rac guanine nucleotide exchange factor (GEF), alsin (ALS2), are causative in juvenile-onset ALS (Hadano et al., 2007) . Indeed, overexpression of active Rac attenuates motor neuron apoptosis and diminished axonal growth following siRNA knockdown of alsin (Jacquier et al., 2006) . Moreover, alsin overexpression antagonizes mutant SOD1-induced NSC34 motor neuronal death via activation
In accordance with previous studies demonstrating a pro-apoptotic function for Rho in diverse models of neuronal apoptosis, expression of the Rho effector, ROCK, is elevated in the spinal cord of G93A mutant hSOD1 mice, suggesting a potential increase due to enhanced Rho activity (Hu et al., 2003) . Thus, enhanced Rho/ROCK signaling may contribute to the selective motor neuron death observed in ALS. Nonetheless, relatively few studies have examined the activation status of Rac and Rho during ALS progression.
In the present study, we examined the involvement of dysregulated Rho family GTPase activity on motor neuron survival in vitro in ESC-derived motor neurons and in vivo in the G93A mutant hSOD1 mouse model of ALS. Targeted inhibition of Rac via NSC23766 treatment or constitutive activation of Rho via CN03 treatment induced neurite retraction and apoptosis of ESC-derived motor neurons. Moreover, in vivo, active Rac1-GTP was significantly decreased in spinal cord motor neurons of G93A mutant hSOD1 mice at disease onset and end-stage when compared to WT littermates.
Finally, we demonstrate that WT motor neurons expressed total RhoB primarily in the nucleus while RhoB redistributed to motor neuron axons of end-stage G93A mutant hSOD1 mice. Collectively, these findings demonstrate that diminished Rac activity and/or elevated Rho activity may contribute to the selective motor neuron degeneration observed in ALS.
Materials and Methods
Reagents NSC23766, Fasudil, and the antibody used to detect choline acetyltransferase (ChAT) were from EMD Millipore (Billerica, MA). Alexafluor 647-conjugated secondary antibody used to detect ChAT staining was from Life Technologies (Carlsbad, CA). CN03 and Y-27632 were purchased from Cytoskeleton (Littleton, CO). The polyclonal antibody used to detect active caspase-3 was from Promega (Madison, WI). The polyclonal antibodies used to immuno-stain for phosphorylated Akt (pAkt; S473), phosphorylated ERK5 (pERK5; T218/Y220), and Bad were from Cell Signaling Technology (Beverly, MA). The monoclonal antibodies used to detect active Rac1-GTP and active RhoA-GTP were purchased from NewEast Biosciences (King of Prussia, PA). The polyclonal antibodies used to detect total RhoB and the
Immunofluorescence microscopy
For green fluorescent images, live fluorescent images were captured using a 20× air objective on an Olympus IX71 microscope with a Diagnostics Insight Spot 2 charge-coupled device (CCD) camera and a Diagnostics capture software analysis program for digital deconvolution (Spot Imaging Solutions, Sterling Heights, MI). For triple fluorescent images, motor neuron cultures were fixed in 4% paraformaldehyde, washed once in phosphate-buffered saline (PBS; pH 7.4), and then permeabilized and blocked in PBS containing 0.2% Triton X-100 and 5% BSA. Cell were incubated for 1 h in primary antibodies diluted in 2% BSA and 0.2% Triton X-100 in PBS and subsequently washed five times in PBS. Next, cells were incubated with DAPI and a Cy3-conjugated secondary antibody diluted in 2% BSA and 0.2% Triton X-100.
The cells were washed five additional times with PBS before the addition of an anti-quench solution composed of 0.1% pphenylenediamine in 75% glycerol in PBS. Fluorescent images were captured using a 63× water immersion objective on a Zeiss Axioplan 2 microscope with a Cooke Sensicam deep cooled CCD camera and a Slidebook software analysis program for digital deconvolution (Intelligent Imaging Innovations Inc., Denver, CO).
Quantification of cell death and neurite integrity
As NSC23766-and CN03-induced cell death resulted in detachment of EGFP+ ESC-derived motor neurons from the culture dish, as an indicator of cell death and neurite integrity, the number of EGFP+ cells in ten randomly selected 20× fields was counted, as was the number of motor neurons with neurites greater than three times the length of their soma.
Typically, 100-200 cells were quantified from each 22.73mm well. Final counts represent the data obtained from at least three independent experiments performed in duplicate.
Animals and clinical signs of ALS
All animal studies were conducted in accordance with a protocol approved by the University of Denver Institutional Animal Care and Use Committee. Wild type FVB (WT) mice and mice expressing G93A mutant hSOD1 on an FVB background were obtained from Jackson Laboratories (http://jaxmice.jax.org/strain/013199.html; Bar Harbor, ME). A colony was established by breeding transgenic male mice with WT female mice. Genotyping was performed by mice corresponding to pre-symptomatic (~60 days-old), disease onset (~90 days-old), and end-stage (~120 days-old) were euthanized in an isoflurane inhalation chamber followed by secondary decapitation. Lumbar spinal cord sections were identified by vertebrae, isolated, and immediately preserved in OCT for immunohistochemical analysis.
Immunohistochemistry
For immunohistochemical studies, 18 micron lumbar spinal cord tissue sections obtained from paired animal sets (each G93A mutant hSOD1 mouse and its WT littermate) were fixed in 4% paraformaldehyde. Next, the sections were blocked in PBS containing 5% BSA and 0.2% Triton X-100. Primary antibodies were diluted in PBS containing 2% BSA and 0.2% Triton X-100 and sections were incubated in primary antibody overnight at 4°C. Next, sections were washed five times in PBS. Sections were then incubated with Hoescht dye and Alexafluor 647-, Cy3-, or FITC-conjugated secondary antibody diluted in PBS containing 2% BSA and 0.2% Triton X-100. Sections were washed five additional times with PBS before the addition of an anti-quench solution composed of 0.1% p-phenylenediamine in 75% glycerol in PBS.
Fluorescent images were captured using a 40× air objective on a Zeiss Axioplan 2 microscope with a Cooke Sensicam deep cooled CCD camera and a Slidebook software analysis program for digital deconvolution (Intelligent Imaging Innovations Inc., Denver, CO).
Immunohistochemical quantification
For paired sets of mice (each G93A mutant hSOD1 mouse and its WT littermate), identical exposure times were used to capture fluorescent fields containing a total of approximately 100 ChAT-positive motor neurons per mouse. The DAPI and ChAT signals were transposed onto a corresponding bright field image of the same field. To select a specific motor neuron for quantitative analysis, only cells with large nuclei and significant ChAT immunofluorescence were chosen. The bright field image was then used to free hand draw an outline of the cell. The outline was then transposed onto the triple fluorescent image. The Rac1-GTP or RhoA-GTP fluorescent signal (red) was then measured within the outlined cell in relative units of average fluorescence intensity per pixel using Adobe Photoshop CS. An average background red fluorescence signal was also calculated for each individual field imaged by measuring the average fluorescence intensity per pixel in regions of the field which were completely devoid of cell nuclei. This background value was then subtracted from each of the individual cell fluorescence values obtained from that specific field. Using this method, the Rac1-GTP and RhoA-GTP fluorescence was quantified from approximately 100 ChAT-positive motor neurons per mouse. Typically, images with high signal-to-noise ratios were most suitable for quantitative analysis. 
Data analysis
Results represent the mean±SEM for the number (n) of independent experiments performed. Statistical differences between the means of unpaired sets of data were evaluated by one-way analysis of variance (ANOVA) with a post hoc Tukey's test or a student's t test. A p value of <0.05 was considered statistically significant. Images are representative of at least three independent experiments.
Results

Generation and differentiation of ESC-derived motor neurons
To examine the involvement of Rho GTPases in regulating the survival of motor neurons, we utilized the HBG3 mouse ESC cell line developed by Wichterle and Peljto (Wichterle et al., 2002; Wichterle and Peljto, 2008) . This ESC line was derived from a transgenic mouse line expressing enhanced green fluorescent protein (EGFP) cDNA under control of the mouse Hb9 promoter. The homeobox gene, Hb9, is expressed selectively by postmitotic motor neurons and is a classical marker of mature motor neuron identity (Arber et al., 1999) . ESC colonies were partially dissociated and grown in aggregate culture in differentiation medium to promote formation of embryoid bodies. After 2 days in aggregate culture, retinoic acid was added to promote differentiation into neural precursor cells ( Fig. 1A ; left panel). Following a 24h exposure to retinoic acid, recombinant sonic hedgehog (SHH) and glial cell line-derived neurotrophic factor (GDNF) were added for an additional 4 days to promote differentiation and survival of spinal motor neurons ( Fig. 1A ; right panel).
Embryoid bodies containing differentiated EGFP+ ESC-derived motor neurons ( Fig. 1B ; top image) were dissociated into single cell suspensions ( Fig. 1B ; middle image) and plated onto dishes coated with matrigel ( Fig. 1B ; lower image and 1C). Following this protocol, approximately 30% of cells terminally differentiated into EGFP-expressing motor neurons 
death of ESC-derived motor neurons
To establish the involvement of Rac GTPase in maintaining survival of ESC-derived motor neurons, motor neuronal cultures were treated with the Rac inhibitor NSC23766. This compound selectively and reversibly hinders GDP/GTP exchange carried out by the Rac-specific GEFs, Tiam1 and Trio, which are significant regulators of Rac in the central nervous system (Schmidt and Hall, 2002; Gao et al., 2004) . In a manner consistent with previous observations in CGNs (Stankiewicz et al., 2015) , ESC-derived motor neuron cultures succumbed to cell death following exposure to targeted Rac inhibition. Incubation with the Rac inhibitor (200M) for only 6h caused significant shrinkage of motor neuron soma and fragmentation of neuronal processes ( Fig. 2A ). Incubation with increasing concentrations of the Rac inhibitor for 24h demonstrated dose-dependent decreases in EGFP+ motor neurons and reductions in the number of cells displaying neurites greater than 3x the length of their soma ( Fig. 2B ). Following 24h of incubation with the Rac inhibitor at a concentration of 200M, these effects were very pronounced with more than 50% of the motor neurons detached from the culture dish and essentially none of the remaining motor neurons exhibiting significant neuronal processes ( Fig. 2C ).
Significantly, co-incubation of motor neurons with the Rac inhibitor and an inhibitor of ROCK (Fasudil) significantly rescued neurites and the total number of surviving motor neurons, indicating that the neurotoxic effects of the Rac inhibitor were specifically leading to an imbalance of Rho/Rac signaling ( Fig. 2D ). Consistent with a critical pro-survival function for Rac, we also observed activation of the death executioner caspase-3 in approximately 30% of the EGFP+ motor neurons that remained attached to the culture dish after a 24h exposure to the Rac inhibitor ( Fig. 3A) . These results indicate that NSC23766-mediated inhibition of Rac in ESC-derived motor neurons elicits cell death via a mechanism consistent with both apoptosis and anoikis.
Selective inhibition of Rac in ESC-derived motor neurons induces de-phosphorylation of ERK5 and AKT and nuclear translocation of the BH3-only protein Bad
In previous studies carried out in primary CGNs, we have demonstrated that NSC23766-mediated Rac inhibition deactivates a pro-survival signaling cascade involving MEK5/ERK5 and AKT, ultimately leading to an induction, dephosphorylation, and mitochondrial localization of the pro-apoptotic BH3-only protein Bad (Stankiewicz et al., 2015) . As anticipated based on these prior results, incubation with NSC23766 similarly induced de-phosphorylation (inactivation) of J o u r n a l P r e -p r o o f Journal Pre-proof the pro-survival proteins ERK5 (T218/Y220) and AKT (S473) in ESC-derived motor neurons ( Fig. 3B and 3C ).
Remarkably, NSC23766 treatment evoked a marked redistribution of the BH3-only protein Bad from a diffuse cytosolic pattern to an exclusively nuclear localization (Fig. 3D ). These findings indicate that inhibition of Rac induces motor neuron death via a mechanism that involves inactivation of critical pro-survival ERK5-and AKT-dependent signaling pathways, in addition to a redistribution of the BH3-only protein Bad from the cytosol to the nucleus.
Constitutive activation of Rho via CN03 treatment induces a marked loss of neurites and death of ESC-derived motor neurons
In a manner similar to loss of active Rac, previous studies have demonstrated that activation of Rho is sufficient to provoke apoptosis in several neuronal models (Bertrand et al., 2007; Semenova et al., 2007; Sanno et al., 2010; Barberan et al., 2011) . Thus, we examined whether a specific activator of Rho, CN03, is toxic to ESC-derived motor neurons.
CN03 is a fusion protein made up of the catalytic domain of a bacterial cytotoxic necrotizing factor and a proprietary cell penetration moiety. CN03 potently and selectively activates Rho by deamidating glutamine 63 within the switch 2 region of the protein, thus locking it in an active conformation (Flatau et al., 1997; Schmidt et al., 1997) . Following a 24h incubation period with CN03, ESC-derived motor neuron cultures displayed an approximately 35% reduction in EGFP+ motor neurons and a nearly 60% decrease in the number of EGFP+ motor neurons with neurites at least three times the length of their soma ( Fig. 4A and 4B ). As anticipated, these data highlight that in a manner similar to inhibition of Rac function, constitutive activation of Rho triggers significant neurite retraction and motor neuron cell death.
Inhibition of ROCK or PTEN significantly protects ESC-derived motor neurons subjected to constitutive Rho activation
CN03 and Fasudil or Y-27632 revealed that inhibition of ROCK conferred significant protection against Rho activation.
As described above, constitutive activation of Rho with CN03 induced an approximately 35% decrease in EGFP+ motor neurons and a nearly 70% decrease in the number of EGFP+ motor neurons with neurites at least three times the length of their soma ( Fig. 5B and 5C ). Co-incubation with Y-27632 significantly preserved motor neuron survival and both ROCK inhibitors significantly protected against neurite retraction. These data support a model in which constitutive activation of Rho induces motor neurite retraction and cell loss that are dependent on activity of the downstream effector ROCK.
ROCK in turn, activates the PTEN phosphatase, which is a potent inhibitor of the pro-survival AKT protein (Wu et al., 2012; Lai et al., 2013) . To determine if constitutive activation of Rho induced motor neuron cell death via a ROCK/PTEN signaling axis, we next evaluated the effects of a PTEN inhibitor on the survival of ESC-derived motor neurons. In ESCderived motor neurons treated with CN03, co-incubation with the PTEN inhibitor bpV significantly preserved neurite integrity ( Fig. 5D ). Collectively, these data demonstrate that constitutive activation of Rho with CN03 induces the death of ESC-derived motor neurons via activation of a specific ROCK/PTEN signaling pathway.
Immunoreactivity of active Rac1-GTP is decreased in ChAT-labeled spinal cord motor neurons from G93A mutant hSOD1 transgenic mice
Our data in ESC-derived motor neurons suggest that Rac activity is essential to maintain motor neuron survival. To begin to unravel the complex role of Rac in ALS disease progression, lumbar spinal cord sections from end-stage (~120 daysold) G93A mutant hSOD1 mice (G93A) and their age-matched WT littermates were stained for DAPI, active Rac1-GTP, and ChAT. Quantification of Rac1-GTP fluorescence intensity revealed that there was markedly reduced Rac1-GTP immunoreactivity in ChAT-positive motor neurons in the spinal cord of end-stage G93A mutant hSOD1 mice when compared to WT controls ( Fig. 6A ). Quantitative analysis showed that the reduction in active Rac1-GTP staining observed in ChAT-positive spinal cord motor neurons of G93A mutant hSOD1 transgenic mice at end-stage was approximately 60%, compared to WT mice ( Fig. 6B ). At disease onset (~90 days-old), this reduction was still statistically significant but was only approximately 25%. No significant reduction in Rac1-GTP staining was observed in ChATpositive motor neurons of transgenic mice at the pre-symptomatic age of 60 days-old ( Fig. 6B ). To our knowledge, these findings are novel in that they are the first to identify a substantial and progressive loss of active Rac1-GTP specifically in spinal cord motor neurons of G93A mutant hSOD1 mice.
J o u r n a l P r e -p r o o f
Rac1-GTP immunoreactivity is enhanced in CD11b-positive microglia of end-stage G93A mutant hSOD1 mice when compared to WT littermates
As noted above, our data in mouse ESC-derived motor neurons, as well as previous work by other groups, indicate an essential pro-survival function for Rac in motor neurons (Jacquier et al., 2006; Pesaresi et al., 2011) . Yet, previous studies have also shown that Rac1 activation within microglia can activate NADPH oxidase to enhance the production of reactive oxygen species (ROS) and significantly contribute to the death of neighboring neurons (Harraz et al., 2008) . To determine whether increased activation of Rac1 in microglia may contribute to the progression of disease in the G93A mutant hSOD1 mouse model of ALS, lumbar spinal cord sections were stained for DAPI, Rac1-GTP, and CD11b. In agreement with aberrant Rac1 GTPase activity contributing to ALS disease progression, we observed increased Rac1-GTP immunoreactivity in CD11b-labeled microglia in the spinal cord of end-stage G93A mutant hSOD1 mice when compared to WT controls (Fig. 7) . Collectively, our data support a model in which aberrant Rac1 activity may contribute to ALS disease progression in a cell type-specific manner; through loss of its pro-survival function in motor neurons and enhancement of its ROS-generating function (via NADPH oxidase or Nox activity) in glial cells.
RhoA-GTP immunoreactivity is not altered in ChAT-labeled motor neurons from G93A mutant hSOD1 mice
Given the antagonistic relationship between Rac and Rho signaling in neurons, we predicted that diminished expression of active Rac1-GTP in ChAT-positive motor neurons in the G93A mutant hSOD1 mouse would correlate with increased expression of active Rho. Although three isoforms of Rho (RhoA, RhoB, and RhoC) have been identified, RhoA activity has been widely demonstrated to provoke apoptosis in a variety of neuronal models (Dubreuil et al., 2006; Semenova et al., 2007; Sanno et al., 2010) . Thus, we stained lumbar spinal cord sections from end-stage G93A mutant hSOD1 mice and their age-matched WT littermates for DAPI, active RhoA-GTP, and ChAT. To our surprise, quantification of RhoA-GTP staining revealed that there was no statistical difference between active RhoA-GTP expression in ChAT-positive motors neurons of end-stage G93A mutant hSOD1 mice when compared to WT control mice (Fig. 8A) . These results suggest that increased activation of RhoA may not contribute to the motor neuronal cell death observed in the G93A mutant hSOD1 mouse model of ALS.
J o u r n a l P r e -p r o o f
Journal Pre-proof
RhoB undergoes a striking redistribution from motor neuron soma and nuclei to axons of G93A mutant hSOD1 mice
In addition to RhoA, enhanced RhoB activation has been demonstrated to be an early marker of neuronal death in a murine stroke model (Trapp et al., 2001) , and cultured corticohippocampal neurons isolated from RhoB knockout mice are significantly less sensitive than WT neurons to apoptosis induced by staurosporine (Barberan et al., 2011) . As there is no specific antibody available to detect active RhoB-GTP, we next stained lumbar spinal cord sections from end-stage G93A mutant hSOD1 mice and their age-matched WT littermates for DAPI, total RhoB, and ChAT. Although the overall expression of RhoB did not appear to be enhanced in motor neurons from end-stage ALS mice, the localization of RhoB was drastically altered. In WT mice, ChAT-positive motor neurons expressed RhoB in a diffuse distribution throughout the nucleus and soma; however, essentially no immunoreactivity was observed in neuronal processes. In marked contrast, motor neurons of end-stage G93A mutant hSOD1 mice demonstrated significant RhoB immunoreactivity within their processes ( Fig. 8B and 8D ). To definitively establish the axonal expression of RhoB in motor neurons, spinal cord sections from end-stage G93A mutant hSOD1 mice and WT mice were stained for DAPI, RhoB, and the vesicular acetylcholine transporter (VAChT). Our data demonstrate that RhoB expression partially co-localizes with the VAChT in motor neuron axons of end-stage G93A mutant hSOD1, but not WT, mice (Fig. 8C) . Interestingly, the redistribution of RhoB from motor neuron soma and nuclei to axons appears to occur at a relatively late stage during disease progression as RhoB was consistently localized to the nuclei and soma of both WT and G93A mutant hSOD1 motor neurons at disease onset (compare Fig. 8D and 8E ). Quantitative analysis showed that at 120 days-old, RhoB was localized to the soma (primarily the nucleus) of approximately 90% of the RhoB-positive cells in the ventral horn of the lumbar spinal cord in WT mice, while RhoB was localized to the processes in approximately 80% of the RhoB-positive cells in G93A mutant hSOD1 mice (Fig. 8F) .
Proposed model depicting the mechanisms by which dysregulated Rho family GTPase activity may contribute to selective motor neuron degeneration in the G93A mutant hSOD1 mouse model of ALS
We propose in healthy spinal cord (Fig. 9A ), microglia retain Rac1 in an inactive GDP-bound state while motor neurons promote pro-survival signaling by maintaining Rac1 in an active GTP-bound state. Furthermore, we propose that RhoB localizes principally to the soma and nucleus of healthy motor neurons. Conversely, in the diseased spinal cord of G93A mutant hSOD1 mice (Fig. 9B ), we hypothesize that enhanced activation of Rac1-GTP in reactive microglia contributes to J o u r n a l P r e -p r o o f Journal Pre-proof the activation of NADPH oxidase and the release of toxic ROS. Furthermore, loss of Rac1-GTP in G93A mutant hSOD1 motor neurons leads to neurite retraction and motor neuron death through deactivation of critical Rac1-dependent prosurvival signaling cascades. Finally, we hypothesize that RhoB re-distribution to axons of motor neurons also contributes to axonal retraction and motor neuron death in G93A mutant hSOD1 mice.
Discussion
It is well documented that Rho family GTPases are key regulators of neuronal survival and apoptosis (Linseman and Loucks, 2008; Stankiewicz and Linseman, 2014) . However, the precise antagonistic relationship between Rac and Rho in motor neuron survival is presently unclear. In addition, whether imbalances in this relationship contribute to neurodegenerative disease states like ALS is also unknown. Inhibition of Rac in embryonic rat spinal motor neurons is sufficient to suppress axon outgrowth and induce cell death (Jacquier et al., 2006) . Moreover, in NSC34 motor neuronlike cells, constitutively active Rac protects from the toxic expression of ALS-causing SOD1 mutants (Kanekura et al., 2005) . Although the involvement of Rho in regulating motor neuron survival is not as well established, RhoA is activated in vulnerable brain regions following either traumatic brain injury or epileptic insult (Dubreuil et al., 2006) , and RhoB -/cortical neurons are significantly less sensitive to apoptotic stimuli than wild type neurons (Barberan et al., 2011) . Thus, the balance of Rac-dependent pro-survival signals and Rho-dependent pro-apoptotic signals appears to be critical for maintaining the survival of multiple neuronal cells types. Herein, we investigated the role of Rac and Rho in regulating motor neuron survival in vitro and whether the balance of these GTPases is altered in a mouse model of ALS.
Our data demonstrate that inhibition of Rac induces neurite fragmentation and death of ESC-derived motor neurons through activation of the executioner of apoptosis, caspase-3, and via deactivation (i.e., de-phosphorylation) of the pro-survival kinases ERK5 and AKT. These results are consistent with our prior findings in primary CGNs which showed that the Rac inhibitor, NSC23766, induces neuronal apoptosis through diminished pro-survival MEK5/ERK5 and AKT signaling (Stankiewicz et al., 2015) . An important pro-survival function of active AKT is to phosphorylate the proapoptotic BH3-only protein Bad to sequester it to 14-3-3 cytosolic scaffolding proteins, effectively diminishing its ability to induce apoptosis at the mitochondria (Zha et al., 1996) . In a similar manner, MEK5/ERK5 signaling has also been shown to phosphorylate Bad via an AKT-independent pathway (Pi et al., 2004) . We have previously shown in NSC23766-treated CGNs, that diminished phospho-AKT and phospho-MEK5/ERK5 are accompanied by the (Stankiewicz et al., 2015) .
Surprisingly, in the present study, we report that NSC23766 treatment evoked a marked redistribution of the BH3-only protein Bad from a diffuse cytosolic pattern to an exclusively nuclear localization in ESC-derived motor neurons. This result differs from the mitochondrial translocation of Bad observed in CGNs exposed to the Rac inhibitor; however, it is an intriguing finding since nuclear localization of Bad has been suggested to stimulate entry of cells into the cell cycle (Chattopadhyay et al., 2001; Al-Bazz et al., 2009) , which is a known trigger of apoptosis in post-mitotic neurons (Folch et al., 2012) .
In addition to the above findings, we also observed that the neurite loss and death of ESC-derived motor neurons induced by the Rac inhibitor were significantly prevented by co-incubation with the ROCK inhibitor Fasudil. These findings demonstrate that the neurotoxic effects of the Rac inhibitor were due in large part to causing a specific imbalance of Rho/Rac signaling within the motor neurons. In other words, when Rac is inhibited, Rho is left unopposed to induce motor neuron apoptosis via aberrant ROCK signaling.
In a manner similar to inhibition of Rac, constitutive activation of Rho in ESC-derived motor neurons via CN03 treatment elicited neurite retraction and apoptosis. Interestingly, the ROCK inhibitors, Fasudil and Y-27632, each protected ESC-derived motor neurons from cell death induced by CN03. Downstream of Rho, ROCK is known to activate the PTEN phosphatase, which is a potent inhibitor of the pro-survival AKT protein (Wu et al., 2012; Lai et al., 2013) . Indeed, inhibition of ROCK utilizing hydroxyfasudil reduced G93A mutant SOD1-induced neurotoxicity in NSC34 motor neuronal-like cells via a mechanism that was dependent on reducing elevated PTEN levels and restoring diminished levels of active AKT (Takata et al., 2013) . As expected, based on these prior studies, co-incubation of ESCderived motor neurons with CN03 and the PTEN inhibitor, bpV, resulted in nearly complete preservation of neurite integrity. Collectively, these data demonstrate that constitutive activation of Rho with CN03 induces the death of ESCderived motor neurons via activation of a specific ROCK/PTEN signaling pathway and subsequent antagonism of prosurvival AKT signaling.
To investigate whether dysregulated Rho family GTPase activity contributes to the etiology of ALS, we next examined the expression of active Rac1-GTP in the spinal cord of G93A mutant hSOD1 mice. In order to conduct this analysis, we chose to perform immunohistochemical staining with an antibody that specifically detects active (GTP-J o u r n a l P r e -p r o o f bound) Rac1. Prior studies have examined the activation state of Rac1 in whole spinal cord lysates obtained from G93A mutant hSOD1 mice using pull down assays and western blotting. For instance, Harraz et al. (2008) used a PAK-protein binding domain pull down assay to evaluate Rac1-GTP levels in spinal cord lysates from end-stage (120 days-old) G93A mutant hSOD1 mice and found that Rac1-GTP was extremely high in the mutants but not detectable in the WT littermates. It is our contention that this result is not reflective of the status of Rac1 activation in spinal cord motor neurons but instead is the result of the significant microgliosis occurring in the end-stage spinal cord. In support of this, Apollini et al. (2013) showed that microglia isolated from neonatal G93A mutant hSOD1 mice already had markedly higher Rac1-GTP levels (measured by PAK pull down assay) than their corresponding WT littermate microglia.
Therefore, we do not believe that one can accurately assess the activation status of Rac1 within spinal cord motor neurons using pull down assays from whole spinal cord lysates due to the large population of activated microglia in the sample.
Using immunohistochemical staining with an antibody that specifically detects active (GTP-bound) Rac1, we report that Rac1-GTP immunoreactivity is significantly decreased in ChAT-positive motor neurons of G93A mutant hSOD1 mice at 120 days-old (end-stage) and 90 days-old (disease onset), but not at 60 days-old (pre-symptomatic), when compared to age-matched WT littermates. To our knowledge, these findings are novel in that they are the first to identify a substantial and progressive loss of active Rac1-GTP specifically in spinal motor neurons of G93A mutant hSOD1 mice. These in vivo data are consistent with our findings demonstrating an essential role for Rac in maintaining ESC-derived motor neuron survival and are further supported by studies reporting that expression of Rac1 can antagonize cell death caused by mutant SOD1 in a variety of neuronal models including primary motor neurons (Kanekura et al., 2005; Jacquier et al., 2006; Pesaresi et al., 2011) . Furthermore, prior data indicate that G93A mutant SOD1 may inactivate Rac1 in a redox-sensitive manner through the growth factor adaptor protein p66Shc (Pesaresi et al., 2011) . While the precise mechanism by which active Rac1-GTP is downregulated in spinal motor neurons of G93A mutant hSOD1 mice remains to be determined, these findings highlight the loss of Rac1 activity as a significant factor in the selective motor neuron death observed in ALS.
Contrary to the loss of active Rac1-GTP observed in spinal cord motor neurons, we show increased Rac1-GTP staining in CD11b-positive microglia of end-stage G93A mSOD1 mice when compared to WT littermates. In agreement with these findings and as stated above, Rac1-GTP is actually upregulated in total spinal cord lysates isolated from endstage G93A mSOD1 mice that display significant microgliosis (Harraz et al., 2008) . Importantly, in addition to its role in neuronal development and survival, Rac1 is required to activate both Nox1 and Nox2, catalytic subunits of NADPH J o u r n a l P r e -p r o o f Journal Pre-proof oxidase, and activation of this complex may contribute to the death of neighboring motor neurons through the generation of toxic superoxide (O 2 -) molecules (Wu et al., 2006; Raz et al., 2010) . Nox1, Nox2, and NADPH oxidase activity are upregulated in spinal cord microglia from genetic mouse models of ALS and ALS patients and previous studies have demonstrated that either genetic deletion or chemical inhibition of Nox1 or Nox2 can slow disease progression and improve survival in familial ALS mice (Wu et al., 2006; Harraz et al., 2008) . Further substantiating a role for enhanced activation of Rac1 in microglia as a causative factor underlying the progression of ALS, mSOD1 stimulates Rac1dependent activation of NADPH oxidase in glial cells expressing ALS-causing SOD1 mutants (Harraz et al., 2008) .
Collectively, these studies indicate that aberrant Rac1 activation in microglia may enhance NADPH oxidase activation and the release of toxic ROS to elicit motor neuron death in G93A mSOD1 mice.
In addition to activation of NADPH oxidase, expression of G93A mSOD1 in microglia leads to the Rac1dependent secretion of pro-apoptotic TNFα and subsequent cell death of neighboring motor neurons in co-culture experiments (Li et al., 2011) . Intriguingly, a recent report demonstrated that oral administration of Fasudil protects against motor neuron loss in the G93A mSOD1 mouse and this occurs at least partially via reduced secretion of TNFα from microglia (Tönges et al. 2014) . G93A mSOD1 may activate Rac1 in microglia through the P2X 7 receptor (Apolloni et al., 2013) , which is responsible for the release of pro-inflammatory factors from microglia, such as TNFα (Skaper et al., 2010) . Although the precise mechanism by which activation of Rac1 in microglia enhances disease progression in the G93A mSOD1 mouse model of ALS requires further investigation; collectively, these data suggest that Rac1 may contribute to neurodegenerative disease through loss of its pro-survival function in motor neurons and enhancement of its ROS-generating function in glial cells.
Given the antagonistic relationship between Rac and Rho in conjunction with extensive evidence implicating
RhoA in neuronal apoptosis, we next evaluated the expression of active RhoA-GTP in ALS mouse spinal cord. We were surprised to find that there was no significant difference between RhoA-GTP expression in G93A mutant hSOD1 and WT motor neurons when evaluated at end-stage of disease. Instead, we report that while total RhoB localized exclusively to the nucleus and soma of WT motor neurons, RhoB displayed a striking redistribution to neuronal processes, including axons, of spinal motor neurons in end-stage, but not disease onset, ALS mice. This may be an important finding given the substantial evidence implicating RhoB in neurite retraction and neuronal apoptosis (Trapp et al., 2001; Conrad et al., 2005; Barberan et al., 2011) . Indeed, in ALS mouse models, analysis of neuromuscular junctions reveals axonal retraction J o u r n a l P r e -p r o o f Journal Pre-proof and denervation prior to loss of alpha motor neuron cell bodies in the lumbar spinal cord and associated development of clinical symptoms (Frey et al., 2000; Fischer et al., 2004) . However, our data suggest that loss of active Rac1-GTP may underlie neurite retraction and motor neuron death in early disease stages (disease onset), while RhoB redistribution to motor axons may contribute to axonal retraction in late disease stages (end-stage) (see Fig. 9 ).
It is presently unclear how RhoB is translocated from a primarily nuclear localization in spinal cord motor neurons of G93A mutant hSOD1 mice at 90 days-old to its dramatic distribution to neuronal processes including motor axons in mice at 120 days-old. We do not know the identity of the molecular signals responsible for inducing this marked change in localization of RhoB during this critical time in disease progression. One possible mechanism may involve the assembly of stress granules and their disruptive effects on nucleocytoplasmic transport. The dysregulation of stress granule dynamics has been implicated in multiple forms of ALS and in particular those associated with mutations in TDP-43 or FUS . A recent study reported that a similar dysregulation of stress granule dynamics is observed in mutant SOD1-induced ALS including the G93A mouse model (Gal et al., 2016) . Furthermore, the aberrant assembly of stress granules has recently been linked to a disruption of nucleocytoplasmic transport in C9Orf72-mediated ALS and frontotemporal dementia (Zhang et al., 2018) . Collectively, these studies suggest that dysregulation of stress granule dynamics, which has been shown to be prominent in G93A mutant hSOD1 mice at disease onset (Gal et al., 2016) , could lead to disruption of RhoB nucleocytoplasmic transport resulting in the redistribution of RhoB from the nucleus to the axons of diseased motor neurons. This hypothesis will require testing to establish its validity, such as inhibiting stress granule assembly via knockdown of either ataxin-2 or the Ras GTPase-activating protein-binding protein G3BP1, which has been shown to interact with mutant SOD1 (Gal et al., 2016) . If the above hypothesis is correct, then knockdown of either of these genes in the G93A mutant hSOD1 mouse should inhibit the redistribution of RhoB from motor neuron nuclei to motor axons and as a result, improve motor function and extend survival in this model of ALS. Takata et al. (2013) administered Fasudil to G93A mSOD1 mice to elucidate the involvement of ROCK activation on the integrity and viability of motor neurons. Indeed, administration of Fasudil reduced motor neuronal loss, slowed disease progression, and extended lifespan of G93A mSOD1 mice. Furthermore ROCK inhibition attenuated elevated PTEN activation while restoring diminished Akt activation. Importantly, in each study examining ROCK inhibition in vivo, Fasudil was administered at a relatively early stage in disease progression (Takata et al., 2013; Tönges et al. 2014 ).
In conjunction with our data implicating RhoB redistribution to neuronal processes in end-stage mice as a potential J o u r n a l P r e -p r o o f Journal Pre-proof causative factor underlying disease progression, these data suggest that ROCK inhibition may prove to be an effective treatment even after disease onset. However, it is important to note that the antibody we utilized detected total RhoB expression as an antibody to active RhoB-GTP is not yet commercially available. Given this limitation, our data aid in clarifying the temporal and cell type-specific role that aberrant Rac1 and/or RhoB activity may contribute to the underlying pathology in the G93A mSOD1 mouse.
In summary, we show that selective inactivation of Rac or constitutive activation of Rho is sufficient to evoke neurite retraction and subsequent cell death of ESC-derived motor neurons. Further confirming the pro-survival role of Rac in motor neurons, we report that Rac1-GTP is significantly reduced in ChAT-positive spinal cord motor neurons of G93A mSOD1 mice, when compared to age-matched WT littermates, at disease onset through end-stage. However, our data indicate that Rac1-GTP is upregulated in microglia from end-stage mice harboring the G93A SOD1 mutation.
Finally, we highlight that although RhoB localizes principally to the soma and nucleus of ChAT-positive motor neurons from WT mice, RhoB redistributes to neuronal processes, including motor neuron axons, in end-stage mice harboring the G93A SOD1 mutation. To our knowledge, these data are novel in that they are the first to reveal the temporal and cell type-specific dysregulation of Rho family GTPases in a familial mouse model of ALS. These findings are in agreement with prior studies showing that ROCK inhibitors have therapeutic potential in mouse models of ALS and are supportive of current clinical studies examining Fasudil as a novel drug for ALS patients (Lingor et al., 2019) . Future studies should examine whether Rac1 is inactivated in spinal motor neurons or RhoB is translocated to motor axons in additional mouse models of ALS (e.g., mutant TDP-43 or FUS) and postmortem tissues from sporadic ALS patients. These experiments would add further support to our hypothesis that an imbalance in signaling between Rac and Rho may underlie the pathogenesis of ALS.
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The authors declare no competing financial interests. 24h, the total number of EGFP+ motor neurons was quantified as was the number of motor neurons with neurites greater than three times the length of their soma. Results shown are the mean±SEM (n=3). C. ESC-derived motor neuron cultures were treated as described in (A). After 24h, the total number of EGFP+ motor neurons was quantified as was the number of motor neurons with neurites greater than three times the length of their soma. Results shown are the mean±SEM of 3 independent experiments performed on duplicate wells. Statistical analyses were performed by a Student's t test (n=3), *p=0.0137, **p=0.0091 vs. Control. D. ESC-derived motor neuron cultures were treated as described in (C) in the absence or presence of Fasudil (Fas; 10M). After 24h, the total number of EGFP+ motor neurons was quantified as was the number of motor neurons with neurites greater than three times the length of their soma. Results shown are the mean±SEM (n=4). Statistical analyses were performed by one-way ANOVA with a post hoc Tukey's test, ***p<0.001 vs. Control, # p<0.05 and ### p<0.001 vs. Rac Inh alone. After 24h, the total number of EGFP+ motor neurons was quantified as was the number of motor neurons with neurites greater than three times the length of their soma. Results shown are the mean ± SEM of 3 independent experiments performed on duplicate wells. Statistical analyses were performed by a Student's t test (n=3), *p=0.0230, **p=0.0064 vs.
Control. ESC-derived motor neuron cultures were incubated in either Con medium or medium containing CN03 in the absence or presence of the PTEN inhibitor, bisperoxovanadium(HOpic) (bpV or PTEN Inh; 500nM). After the 24h incubation period, the number of motor neurons containing neurites at least 3x the length of the soma was quantified and expressed as a percentage of the total number of EGFP+ motor neurons in each well. Results shown are the mean±SEM (n=3). Statistical J o u r n a l P r e -p r o o f Journal Pre-proof analyses were performed by one-way ANOVA with a post hoc Tukey's test, **p<0.01 vs. Control; ## p<0.01 vs. CN03 alone. Figure 6 . Rac1-GTP immunoreactivity is decreased in ChAT-labeled motor neurons from G93A mutant hSOD1 mice. A. Spinal cords (lumbar portion) from end-stage (~120 days-old) mice harboring the G93A hSOD1 mutation (G93A) or WT littermates were cryo-sectioned into 18μM sections. Sections were stained for DAPI (blue), active Rac1-GTP (red), and choline acetyltransferase (ChAT; to label motor neurons; green). Note that Rac1-GTP immunoreactivity is consistently high in WT motor neurons but is substantially decreased in ChAT-positive cells from G93A mutant mice.
Arrows indicate prominent ChAT-positive motor neurons. Scale bar=20 microns. B. Lumbar spinal cord tissue was stained as described in (A) and the active Rac1-GTP signal was quantified for paired sets of mice (each pair consisting of an end-stage G93A mutant hSOD1 mouse (mSOD1) and its age-matched WT littermate) at end-stage (~120 days-old), disease onset (~90 days-old), and pre-symptomatic (~60 days-old). The graph shown represents the average fluorescence (lumbar portion) from end-stage mice (~120 days-old) harboring the G93A hSOD1 mutation (G93A) or WT littermates were cryo-sectioned into 18μM sections. Sections were stained for DAPI, active RhoA-GTP, and ChAT (to label motor neurons). The graph shown represents the average fluorescence intensity (per pixel) for the RhoA-GTP signal per ChATpositive cell and is presented as the mean ± SEM for 3 paired sets of mice (each pair consisting of an end-stage G93A mutant hSOD1 mouse (mSOD1) and its age-matched WT littermate). Values are expressed as a percentage of the WT signal. NS denotes not significant compared by a paired t-test (n=3). B. Spinal cords were processed and cryo-sectioned as described in (A). Sections were stained for DAPI (blue), RhoB (red), and ChAT (to label motor neurons; green). Note that RhoB immunoreactivity is not observed in neuronal processes of WT motor neurons but brightly labels processes of ChAT-positive cells from G93A mutant hSOD1 mice. C. Spinal cord sections were stained for DAPI (blue), RhoB (red), and vesicular acetylcholine transporter (VAChT; to label motor neuron axons; green). Note that RhoB immunoreactivity is not observed in neuronal processes of WT motor neurons but brightly labels VAChT-positive axons of motor neurons from G93A mutant hSOD1 mice (arrowheads indicate sites of co-localization between RhoB and the VAChT). D. Lumbar spinal cord tissue was stained as described in (B) for 3 paired sets of end-stage mice (~120 days-old). Note that in each animal set, RhoB immunoreactivity is not observed in neuronal processes of WT motor neurons but brightly labels processes of ChAT-positive cells from G93A mutant hSOD1 (mSOD1) mice. Arrowheads indicate RhoB expression in motor neuron processes. The two right hand panels show 2.5x magnifications of the areas demarcated by the boxes. E.
Lumbar spinal cord tissue was stained as described in (D) for 3 paired sets of disease onset mice (~90 days-old). Note that in each animal set, RhoB expression principally localizes to the soma and nucleus of ChAT-positive motor neurons in both WT and G93A mutant hSOD1 mice. The two right hand panels show 2.5x magnifications of the areas demarcated by the boxes. Scale bars=20 microns. F. RhoB localization was quantified in the lumbar spinal cord for 5 paired sets of endstage mice. Briefly, approximately 10 ventral horns were analyzed per mouse and the fraction of cells with RhoB expression localized to the soma (primarily the nucleus) or the processes was determined for each mouse. Data represent the mean ± SEM for 5 paired sets of mice (each pair consisting of an end-stage G93A mutant hSOD1 mouse (G93A) and its age-matched WT littermate). Statistical analyses were performed by unpaired Student's t test (n=5); ***p < 0.001 compared to WT. 
